BNP Paribas Asset Management
NBIX icon

BNP Paribas Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$130M Sell
1,032,296
-222,810
-18% -$28M 0.32% 62
2025
Q1
$139M Buy
1,255,106
+310,368
+33% +$34.3M 0.37% 54
2024
Q4
$129M Buy
944,738
+124,770
+15% +$17M 0.32% 68
2024
Q3
$94.5M Buy
819,968
+37,098
+5% +$4.27M 0.23% 99
2024
Q2
$108M Sell
782,870
-7,323
-0.9% -$1.01M 0.28% 81
2024
Q1
$109M Buy
790,193
+69,600
+10% +$9.6M 0.29% 77
2023
Q4
$94.9M Buy
720,593
+42,263
+6% +$5.57M 0.26% 94
2023
Q3
$76.3M Buy
678,330
+21,308
+3% +$2.4M 0.23% 107
2023
Q2
$62M Buy
657,022
+44,368
+7% +$4.18M 0.19% 130
2023
Q1
$62M Buy
612,654
+61,297
+11% +$6.2M 0.21% 114
2022
Q4
$65.9M Buy
551,357
+17,851
+3% +$2.13M 0.24% 109
2022
Q3
$56.7M Buy
533,506
+85,689
+19% +$9.1M 0.22% 106
2022
Q2
$43.7M Buy
447,817
+88,840
+25% +$8.66M 0.17% 143
2022
Q1
$33.7M Sell
358,977
-13,615
-4% -$1.28M 0.12% 210
2021
Q4
$31.7M Sell
372,592
-19,158
-5% -$1.63M 0.11% 235
2021
Q3
$37.6M Sell
391,750
-1,192
-0.3% -$114K 0.14% 184
2021
Q2
$38.2M Buy
392,942
+69,482
+21% +$6.76M 0.14% 190
2021
Q1
$31.5M Buy
323,460
+65,431
+25% +$6.36M 0.13% 186
2020
Q4
$24.7M Sell
258,029
-5,867
-2% -$562K 0.11% 215
2020
Q3
$25.4M Buy
263,896
+42,543
+19% +$4.09M 0.14% 176
2020
Q2
$27M Sell
221,353
-14,531
-6% -$1.77M 0.18% 151
2020
Q1
$20.4M Buy
235,884
+32,994
+16% +$2.86M 0.17% 160
2019
Q4
$21.8M Sell
202,890
-95,184
-32% -$10.2M 0.15% 189
2019
Q3
$26.9M Sell
298,074
-106,738
-26% -$9.62M 0.21% 136
2019
Q2
$34.2M Buy
404,812
+37,933
+10% +$3.2M 0.28% 90
2019
Q1
$32.3M Buy
366,879
+186,150
+103% +$16.4M 0.27% 89
2018
Q4
$12.4M Sell
180,729
-11,723
-6% -$802K 0.11% 248
2018
Q3
$23.7M Sell
192,452
-53,695
-22% -$6.6M 0.18% 155
2018
Q2
$24.2M Buy
246,147
+136,401
+124% +$13.4M 0.2% 133
2018
Q1
$9.1M Sell
109,746
-141,453
-56% -$11.7M 0.08% 343
2017
Q4
$19.5M Sell
251,199
-271,602
-52% -$21.1M 0.17% 161
2017
Q3
$32M Buy
522,801
+133,175
+34% +$8.16M 0.27% 80
2017
Q2
$17.9M Buy
389,626
+180,437
+86% +$8.3M 0.16% 165
2017
Q1
$9.06M Buy
209,189
+23,782
+13% +$1.03M 0.08% 336
2016
Q4
$7.18M Buy
185,407
+14,615
+9% +$566K 0.07% 385
2016
Q3
$8.65M Sell
170,792
-12,471
-7% -$632K 0.07% 365
2016
Q2
$8.33M Buy
183,263
+124,022
+209% +$5.64M 0.07% 361
2016
Q1
$2.34M Buy
+59,241
New +$2.34M 0.02% 645
2015
Q2
Sell
-17,231
Closed -$684K 1060
2015
Q1
$684K Sell
17,231
-1,632
-9% -$64.8K 0.01% 896
2014
Q4
$421K Buy
+18,863
New +$421K ﹤0.01% 866
2013
Q4
Sell
-184,125
Closed -$2.08M 840
2013
Q3
$2.08M Sell
184,125
-56,452
-23% -$639K 0.02% 590
2013
Q2
$3.22M Buy
+240,577
New +$3.22M 0.02% 525